|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Foreign exchange loss | |||||
| Depreciation of fixed assets | |||||
| Amortization of intangible assets | |||||
| Amortization of right-of-use assets | |||||
| (Accretion of discount)/amortization of premium on investments | |||||
| Change in contingent consideration liability | |||||
| Loss on disposal of assets | |||||
| Amortization of debt issuance costs | |||||
| Share-based compensation | |||||
| Change in fair value of financial instrument | |||||
| Loss on extinguishment of debt | |||||
| Loss on disposal of property and equipment | |||||
| Non-cash interest settled through share conversions | |||||
| Impairment of fixed assets | |||||
| Credit loss expense | |||||
| Inventory net realizable value adjustment | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Earn out payable | |||||
| Right-of-use liabilities | |||||
| Contract liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Redemptions of short-term investments | |||||
| Purchases of short-term investments | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Cash paid for tax withholding related to shares withheld | |||||
| Payment of debt issuance costs | |||||
| Proceeds from convertible notes | |||||
| Payment on convertible notes | |||||
| Proceeds from issuance of common stock - At The Market offering, net of issuance costs | |||||
| Proceeds from issuance of common stock - Capital Raise, net of issuance costs | |||||
| Proceeds from issuance of common stock - AGP At The Market offering, net of issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Common stock issued related to bonus and earnout payments | |||||
| Common stock issued related to conversion of convertible debt | |||||
| Operating right of use asset obtained in exchange for operating lease liability | |||||
Loading...